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Abstract Chronic polymicrobial lung infections in adult
cystic fibrosis patients are typically dominated by high
levels of Pseudomonas aeruginosa. Determining the
impact of P. aeruginosa growth on airway secretion com-
position is fundamental to understanding both the behav-
iour of this pathogen in vivo, and its relationship with other
potential colonising species. We hypothesised that the
marked differences in the phenotypes of clinical isolates
would be reflected in the metabolite composition of spent
culture media. 1H NMR spectroscopy was used to char-
acterise the impact of P. aeruginosa growth on a synthetic
medium as part of an in vitro CF lower airways model
system. Comparisons of 15 CF clinical isolates were made
and four distinct metabolomic clusters identified. Highly
significant relationships between P. aeruginosa isolate
cluster membership and both patient lung function (FEV1)
and spent culture pH were identified. This link between
clinical isolate growth behaviour and FEV1 indicates
characterisation of P. aeruginosa growth may find appli-
cation in predicting patient lung function while the sig-
nificant divergence in metabolite production and
consumption observed between CF clinical isolates
suggests dominant isolate characteristics have the potential
to play both a selective role in microbiota composition and
influence pseudomonal behaviour in vivo.
Keywords NMR  Cystic fibrosis  Pseudomonal  Lung
function
1 Introduction
Chronic lung disease is the main determinant of morbidity
and mortality in cystic fibrosis (CF) (Emerson et al. 2002;
Rosenfeld et al. 2001), with bacterial infection considered a
key driver in this process (Kosorok et al. 2001). Pseudo-
monas aeruginosa is a species that has long been regarded
as a pathogen in the CF lung (CF Foundation 2007) and
whose presence is associated with reduced life expectancy
(Lyczak et al. 2002). With the exception of end stage
disease (Bjarnsholt et al. 2010), P. aeruginosa, though
common, is only one of many species forming the bacterial
microbiota associated with the CF lower airways by
adulthood (Rogers et al. 2004; Armougom et al. 2009).
Moreover, though the bacterial species reported in CF
typically vary markedly between individuals (Stressmann
et al. 2011); these colonising species are less phylogenet-
ically diverse than the pool of bacterial species reported as
passing transiently through the lower airways of healthy
individuals (Rogers et al. 2006). Together, these factors
suggest that the development of CF airway bacterial
communities is a selective process, and that this selection
differs between individuals. Exposure to an ‘‘infective
dose’’ equivalence of a given species will be required for
‘‘infection’’ to occur. However, the existence of a group of
core species, that is commonly but not universally reported
(van der Gast et al. 2011), suggests that infection is not due
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to chance alone. The factors underpinning selection remain
unclear; however the identification of key selective drivers
offers the possibility of identifying those patients who are
at greatest risk of developing a lower airway infection by a
specific pathogen.
There are a number of factors that differ between CF
patients that might contribute to such selection. For
example, the severity of the underlying impairment of
CFTR function (a trans-epithelial ion transport protein)
(Dean and Santis 1994), the degree to which oxygen ten-
sion in airway secretions is reduced as a result of neutro-
philic influx (Kolpen et al. 2010), and antibiotic treatment
history (Stressmann et al. 2011; Tunney et al. 2011). Here,
we investigate the extent of a further potential selective
force; the nutritional characteristics of secretions in the
airways. Whilst differences in secretion rheology may arise
as a result of the range of CFTR defect severities (Boucher
2004), there is no evidence to suggest that the chemical
composition of the secretions differs substantially between
individuals at the point when they are produced. However,
these secretions are typically colonised by high levels of P.
aeruginosa (commonly 106–109 cfu/ml; Aaron et al. 2004;
Stressmann et al. 2011). P. aeruginosa growth will, in turn,
reduce the availability of certain carbon and nitrogen
sources, and produce a wide range of metabolites. Such
shifts in nutritional sources are known to influence bacte-
rial community composition in other contexts (Resat et al.
2012; Dunaj et al. 2012). Together, these changes will
result in an altered growth environment, potentially influ-
encing the likelihood of successful colonisation by new
bacterial species entering the lower airways, and the gene
expression and growth strategies of P. aeruginosa itself
(Bernier et al. 2011).
Pseudomonas aeruginosa isolates from different CF
patients are known to exhibit a broad range of phenotypic
characteristics, employ a number of different growth
strategies in vivo, including planktonic and biofilm modes
(Ciofu et al. 2012), and exploit a wide range of carbon and
nitrogen sources (Frimmersdorf et al. 2010). We therefore
hypothesised that P. aeruginosa CF airway isolates differ
in the manner in which they modify the composition of the
airway secretions in which they grow, resulting in signifi-
cant differences in the nutritional growth environment
available to the CF airway bacterial community. Charac-
terisation of such biochemical signatures requires the
determination of changes in the levels of a large number of
molecules. Consequently, we used 1H NMR spectroscopy
to obtain an overview of the compositional changes that
occur in a defined synthetic CF medium (SCFM) as a result
of the growth of these isolates in an in vitro CF airway
model. 1H NMR spectroscopy has been used previously to
investigate the growth of P. aeruginosa type strain PAO1
in Luria–Bertani broth, a standard laboratory medium
(Gjersing et al. 2007). Here, we aimed to more closely
replicate the physiochemical composition of CF airway
secretions in a controlled manner and cultured clinical
isolates in SCFM. Previous studies comparing P. aeru-
ginosa gene expression in CF sputum with that in similar
CF synthetic media have shown bacterial behaviour to be
similar in the two contexts (Palmer et al. 2007; Fung et al.
2010). By combining 1H NMR spectroscopy with this CF
airway growth model, we were therefore able to assess the
degree to which the impact of P. aeruginosa growth dif-
fered between clinical isolates under conditions approxi-
mating those encountered in vivo. We report substantial
variation in the observed spent media metabolomes and
show that the variation between different clinical isolates is
related to variation in clinical measures of respiratory
disease.
2 Materials and methods
Sputum samples were collected from 13 adult CF patients
with ethical approval from Southampton and South West
Hampshire Research Ethics Committee (06/Q1704/26).
The collection of these samples has been described previ-
ously (van der Gast et al. 2011; Stressmann et al. 2011). P.
aeruginosa isolates were recovered from these samples by
inoculation on P. aeruginosa selective medium (CM0559
plus SR0103, Oxoid, Cambridge, UK). A representative
colony of the numerically dominant morphotype was
selected for each patient. In the case of Patients 12 and 13,
two prevalent morphotypes were isolated concurrently,
with both carried forward for analysis. Details of isolates,
phenotypic characteristics, and the patients from which
they were obtained, are presented in Table 1.
Bacterial species diversity in these samples was previ-
ously determined by 16S rRNA gene clone sequencing
(van der Gast et al. 2011). Spent culture pH was deter-
mined at 37 C using an InLab Micro Pro pH electrode and
Mi150 pH meter (Mettler Toledo, Leicester, UK). All P.
aeruginosa isolates were screened for auxotrophy as
described previously (Barth and Pitt, 1995). These data are
also presented in Table 1.
2.1 Bacterial growth conditions
Pseudomonas aeruginosa in the CF lung grows in stagnant
mucus, an environment that is characterised by microaer-
ophilic and anaerobic conditions (Worlitzsch et al. 2002;
Yoon et al. 2002). To reflect these in vivo sputum condi-
tions, the following growth model was employed. A
defined synthetic CF medium (SCFM) was used, based on
a number of different CF synthetic media described pre-
viously (Sriramulu et al. 2004; Palmer et al. 2005; Palmer
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et al. 2007; Fung et al. 2010). The SCFM used contained
10 g/L BSA, 10 g/L porcine gastric mucin, 1.4 g/L herring
sperm DNA, 10 mM MOPS, 5 g/L egg yolk emulsion,
3.6 lM FeSO4, 51.8 mM NaCl, 2.28 mM NH4Cl,
2.128 mM L-lysineHCl, 14.9 mM KCl, 1.78 mM L-alanine,
1.754 mM CaCl2, 1.661 mM L-proline, 1.609 mM L-leucine,
1.549 mM L-glutamateHCl, 1.446 mM L-serine, 1.3 mM
NaH2PO4, 1.25 mM Na2HPO4, 1.203 mM L-glycine,
1.12 mM L-isoleucine, 1.117 mM L-valine, 1.072 mM L-thre-
onine, 0.827 mM L-aspartate, 0.802 mM L-tyrosine, 0.676
mM L-ornithineHCl, 0.633 mM L-methionine, 0.606 mM
MgCl2, 0.53 mM L-phenylalanine, 0.519 mM L-histidine
HCl, 0.348 mM KNO3, 0.306 mM L-arginineHCl, 0.16
mM L-cysteineHCl, 0.119 mM diethylene triamine penta-
acetic acid, 0.013 mM L-tryptophan. The pH of the medium
was adjusted to 6.8. Media was sterilised by passage through
a a 0.45-lm-pore-size syringe filter, except for porcine
gastric mucin, which was sterilised separately by heating at
70 C for 24 h in 95 % ethyl alcohol, as described previously
(Mitsui et al. 1976).
Incubation was performed in 9 ml volumes of SCFM in
15 ml Falcon tubes (BD Biosciences, Oxford, UK) with
tight lids, for 72 h at 37 C, with inversion every 12 h, in
order to to replicate reduced oxygen tensions and low
relative physical disruption of the CF lower airways. Fol-
lowing incubation, bacterial cells were pelleted by centri-
fugation at 12,0009g, 10 min at 4 C, with the supernatant
transferred to fresh NMR tubes with 10 % v/v D2O added
to provide a deuterium lock signal.
2.2 NMR
1H NMR spectra were recorded on a Bruker Avance
400 MHz spectrometer equipped with a 5 mm QNP probe
(Bruker UK Limited, Coventry, UK) with sample isolates
tested in triplicate (three independent cultures from the
same colony) and kept at room temperature. A zgesgp
pulse sequence (Bruker) with excitation sculpting using
gradients was used (Hwang and Shaka 1995). The 1H 90
degree pulse was 9.75 ls. For each spectrum, 65,536 data
points were acquired with 16 scans. To help in the
assignment of the metabolite resonances, J-resolved 2D
correlation with pre-saturation during relaxation delay
using gradients (J-Res, Bruker) spectra were recorded for
some of the samples, using default pulse sequences as
provided by Bruker. The spectral width was 20 ppm. Free
induction decays were multiplied with an exponential
function corresponding to a line broadening of 0.3 Hz. The
spectra were Fourier transformed and calibrated to a
2,2,3,3,-D4-3-(Trimethylsilyl) propionic acid sodium salt
(TSP-2,2,3,3-D4) reference signal at 0 ppm. Phase cor-
rection was performed manually and automatic baseline
correction was applied.
2.3 Bacterial quantification
P. aeruginosa density in samples at harvesting was deter-
mined by quantitative (Q) PCR enumeration of oprL gene
copies in total DNA extracts, using a protocol described
previously (Feizabadi et al. 2010). All Q-PCR reactions
were carried out in a total volume of 25 ll using Taqman
Universal PCR Mastermix (Applied Biosystems, War-
rington, UK). Quantitative PCR assays were carried out
using the Rotorgene 6000 (Qiagen, Crawley,UK) with a
temperature profile of 50 C for 2 min, 95 C for 10 min,
followed by 45 cycles at 95 C for 15 s and 60 C for 60 s.
The cycling program was adjusted at 95 C for 10 min and
then 35 cycles of 10 s each at 95 C (denaturation) fol-
lowed by 35 s at 60 C with fluorescent collection
(annealing and extension). Analysis was performed in
triplicate and the mean reported.
2.4 P. aeruginosa strain genotyping
Random Amplified Polymorphic DNA (RAPD) assays
were performed for each P. aeruginosa isolate as described
previously (Renders et al. 1996) using the primer ERIC2
(50-AAGTAAGTGACTGGGGTGAGCG-30). In those iso-
lates not distinguishable based on the resulting profile, a
further RAPD profile using the primer ERIC1 (50-AT-
GTAAGCTCCTGGGGATTCAC-30) was performed. PCR
reactions were performed in 25 ll volumes, containing
REDTaq ReadyMix PCR Reaction Mix (Sigma-Aldrich,
Dorset, United Kingdom) with the addition of MgCl2 to
achieve a final concentration of 2.5 mM. Primers were
used at a concentration of 0.5 lM and 50 ng of template
DNA. Reactions were performed as follows: An initial
denaturation step of 94 C for 2 min was followed by 32
cycles of denaturation at 94 C for 1 min, annealing at
25 C for 1 min, and extension at 72 C for 2 min, with a
final extension step at 72 C for 10 min. Amplification was
carried out by using a GeneAmp PCR System 2400 (Per-
kin-Elmer), and verified on Tris–acetate-EDTA–agarose
gel electrophoresis and analysed using Phoretix 1D
advanced software, version 5.0 (Nonlinear Dynamics,
Newcastle upon Tyne, UK).
2.5 Multivariate analysis
Pre-processing and orthogonal projection to latent structures
discriminant analysis (OPLS-DA) were carried out with
software that was developed in our laboratory for a previous
study (Vermeer et al. 2012) using the python programming
language with numpy and scipy for calculations, and mat-
plotlib for visualization. The nonlinear iterative partial least-
squares (NIPALS) algorithm (Andersson 2009) was used for
OPLS-DA analysis.
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Regions above 9.074 ppm and below 0.116 ppm were
excluded because of noise content. The water peak, ethanol
and TSP reference signal were also excluded. The spectra
were bucketed using 0.02 ppm bin size with additional,
manual bucketing applied to adjust for peak shifting as
described below, leaving 336 data points per spectrum.
Spectra were normalized using probabilistic quotient nor-
malisation (Dieterle et al. 2006).
Principal component analysis (PCA) was used to identify
clustering patterns from the major variations between the 49
NMR spectra. For this analysis, spectra were pareto-scaled
after normalisation. In order to further investigate the com-
pounds discriminating between clusters and provide a robust
statistical analysis of putative cluster membership, each
possible cluster was analysed against SCFM using orthog-
onal partial least-squares discriminant analysis (OPLS-DA).
Here, spectra were auto-scaled (variance of every data point
normalized to 1). Both normalisation and auto-scaling were
included in the cross-validation procedure (Supplementary
Table 1). Cross-validation was performed where 75 % of the
samples were used as a training set and the remaining 25 %
as a test set, ensuring that the number of samples in the test
set was proportional to the total number of samples from
each class, and that at least one sample from each class was
present in the test set. To choose the number of components
for the model, a leave-one-out cross-validation was carried
out on the samples in the training set, and the F1 used to
choose the number of components, with the additional
constraint to use a maximum of 10 components. This double
cross-validation was repeated 2,000 times with randomly
chosen samples in the training and test set to prevent bias due
to the choice of training or test set. This leads to 4 9 2,000
models (in the supplementary information, each of these
models leads to a point on the scores plot, but loadings and
weights are presented as averages over all these models).
Finally, this procedure was repeated with randomly gener-
ated class assignments to provide a reference value for Q2.
The chosen number of components minus one was then used
as an OPLS filter and a PLS-DA analysis with two compo-
nents was carried out on the filtered data to yield one pre-
dictive and one orthogonal component. Back-scaled
loadings (Cloarec et al. 2005) were used to identify reso-
nances with high variance and high weight, therefore the
discriminating resonances, and verified against the peak
intensity of the original spectra after PQN normalisation.
Peaks that allow the models to distinguish between
classes were assigned by comparing chemical shift values
and multiplicities from J-resolved NMR spectra to values
from the BMRB (Ulrich et al. 2007) and HMDB (Wishart
et al. 2009), analysis of published P. aeruginosa metabolic
data (Son et al. 2007; Frimmersdorf et al. 2010) and NMR
spectra generation from individual medium components
was used to help in the assignment.
2.6 Relationships between PCA and clinical
characteristics
One-way factorial ANOVA were performed to test for
significant relationships between the P. aeruginosa strain
cluster membership and sample characteristics, with a
significance threshold of p \ 0.05. Homogeneity of vari-
ance and normality of errors were assessed using the
Fligner-Killeen and the Shapiro–Wilk tests respectively
prior to the ANOVA. If a factor failed either test a non-
parametric Kruskal–Wallis rank sum test was performed.
Factors that were found to be significant using the ANOVA
were further studied using Tukey’s honest significant dif-
ference (HSD) as a post hoc test. Correlations between the
sample characteristics were performed using Spearman’s
rho correlations. Statistical analyses were performed using
R (v.2.13.0, www.r-project.org).
3 Results
3.1 1H NMR spectroscopy of Pseudomonas CF isolates
cultured in an airway model medium
1H NMR spectroscopy has been used previously to inves-
tigate the growth of P. aeruginosa type strain PAO1 in
Luria–Bertani broth, a standard laboratory medium (Gjer-
sing et al. 2007). Here, we aimed to more closely replicate
the physiochemical composition of CF airway secretions in
a controlled manner and cultured clinical isolates in SCFM.
Representative 1D 1H NMR spectra are shown for each of
the isolate clusters identified by the principal component
analysis described below, revealing the effect of culturing
either P. aeruginosa PAO1 or CF clinical isolates (Fig. 1).
Insufficient growth of isolate 6 occurred in SCFM medium
and hence it was excluded from further analysis. Spectra
generated from either sterile medium, or media inoculated
by a particular strain showed a high degree of reproduc-
ibility in multiple independent replicates. Although we
were successful in identifying metabolite changes that are
linked to clinical measures, as described below, adherence
to the well validated SCFM growth procedures presented
some challenges for the NMR studies and subsequent
multivariate analysis. In order to remain relevant to CF
airway secretion composition, SCFM contains a number of
components, such as mucin and BSA, which could result in
peak broadening and loss of resolution due to high vis-
cosity (Supp. Fig. 1). In addition, a number of the strains
analysed were highly mucoid and were capable of pro-
ducing large amounts of exopolysaccharide (EPS). Finally,
although less noticeable in the SCFM spectrum, resonances
attributable to the, presumably, non-metabolised MOPS
buffer dominate the spectra derived from spent media.
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These factors led to a number of very broad resonances,
particularly between 3.5 and 4.5 ppm, and substantial, pH
dependent shifting of both broad and sharper resonances
between 3.00 and 3.30 ppm and around 2.10 ppm, (Fig. 1)
as expected from the pH dependence of buffer resonance
chemical shifts (Supp. Fig. 2). To remove the influence of
MOPS buffer from the analysis, the following regions were
excluded in addition to the water and ethanol peaks
(5.02–4.65 ppm; 3.70–3.76 and 1.22–1.15 ppm): 4.02–3.87
ppm; 3.50–2.87 and 2.27–1.96 ppm. Ultimately, this has a
number of implications for how the data may be treated and
the degree of resonance assignment that is possible. Large
scale shifting of buffer resonances resulted in ineffective
peak alignment using correlation optimized warping
(COW) (Tomasi et al. 2004) (Supp. Fig. 3). Although peak
realignment could conceivably be achieved through pH
adjustment of spent media as is done for e.g. urine samples
(Beneduci et al. 2011), manual peak bucketing was able to
account here for the observed peak shifts. The exclusion of
large regions, considerable spectral overlap and the
appearance of broad resonances following bacterial growth
also precluded the use of statistical correlation spectros-
copy (STOCSY) or other two-dimensional techniques to
aid assignment for many resonances. For this reason our
present efforts were largely restricted to using the 1H NMR
technique and multivariate analysis to group the isolates
according to apparent differences in growth strategies.
3.2 PCA identifies putative clusters based on isolate
scores
Principal component analysis (PCA) was used to identify
clustering patterns between spectra obtained for the clinical
isolates (n = 41) and SCFM medium (n = 8). The repre-
sentative 2D scores plots of component 1 (PC1) versus
component 2 (PC2), which explain 67.7 % of the variation
in the spectra, reveal four putative separate clusters rep-
resenting the different biochemical composition of the
samples as detected by the NMR spectra (Fig. 2). In the
PCA scores plot, each data point corresponds to one 1D 1H
NMR spectrum, and the reproducibility of the method was
supported by the close arrangement of data points corre-
sponding to replicates from each isolate (Fig. 2).
NMR spectra obtained from media inoculated with each
of the CF clinical isolates fell into two, readily identifiable,
main clusters (I/II) that were distinguished on the basis
their relative separation in PC1. The second of these
clusters is possibly subdivided into two or three further
putative clusters (IIa-c) since the isolates were further
separated in PC2, with groups of isolates in separate
quadrants of the PCA scores plot. The spectra from isolates
in the three or four clusters were each well separated from
those of the sterile synthetic media with the exception of
isolate 1 which caused almost no change in the 1H NMR
spectra of the spent media.
Cluster I was mostly separated from SCFM by PC2.
Three of the four isolates found in Cluster I (1, 10, 12b) are
notable in that they lead to a very acidic pH in the spent
media (Table 1). This might cause the cluster members to
be distinguished purely on the basis of pH dropping below
pH 6.0 which causes MOPS resonances to shift even
beyond the ranges excluded above (Supp. Fig. 2). A broad
resonance at 4.04 ppm does appear for these isolates which
can be assigned to the MOPS resonance expected in this
region, however additional MOPS resonances expected
between 3.50 and 3.87 ppm could not be discerned above
the contribution from metabolite resonances.
Cluster II was further separated from SCFM by PC1 but
subdivision of Cluster II was expected since isolates were
also well distributed along PC2 and were separated into
upper and lower quadrants. Initially a three cluster model
was considered with Cluster IIa in the lower quadrant and
Cluster IIb in the upper quadrant. The existence of a fourth
putative Cluster IIc, with isolates located intermediate to
Clusters IIa and IIb, was considered and tested by OPLS-DA
below. Key resonances whose variation contributes to PC1
Fig. 1 Representative 1H NMR spectra generated from non-inocu-
lated SCFM, PAO1 inoculated SCFM, and representative members of
each of the four putative clinical isolate clusters. Shaded regions
indicate large regions of the 1H NMR spectra excluded on the basis of
solvent or buffer peaks
Metabolomic analysis of CF P. aeruginosa isolates 1267
123
and PC2 are shown in the corresponding PC loadings plot
(Supp. Fig. 4).
3.3 OPLS-DA supports clusters identification
Orthogonal projection to latent structures discriminant anal-
ysis (OPLS-DA) was then used to compare 1H NMR spectra
data generated from sterile synthetic media with each of the
four putative strain clusters and to test whether the clusters
could indeed be considered separate. Cross-validation was
performed on all models (Supp. Fig. 5–8). The resulting 2D
scores plots show good separation between the three or four
putative clusters and SCFM with Q2 values[0.90, indicating
a highly reliable model compared with an ideal score of 1
(Table 2). Initially, the PCA scores plot readily identified two
separate isolate scores clusters (Cluster I/Cluster II) with
Cluster I, comprising isolates 1, 3, 10 and 12b, well removed
from the remaining isolates. The subdivision of Cluster II was
tested; putative Clusters IIa and IIb, containing isolates 4, 7,
11, 13, 14 and 2, 5, 9, 12, 13b respectively, could be separated
(Supp. Fig. 8; Q2 = 0.69) using OPLS-DA. However when a
further putative cluster (IIc) was considered, comprising iso-
lates 2, 4, 5 and 14 (PCA scores for these isolates show an
intermediate distribution between the upper and lower quad-
rants due to PC2), the apparent separation as monitored by
scores plots (Suppl. Fig. 6/7) and Q2 (Table 2) indicated that a
four cluster model may be useful when greater numbers of
patient isolates are available.
3.4 Relationships between strain cluster membership
and sample characteristics with 1D 1H NMR
spectra
To determine whether differences in the nutritional modi-
fications to airway secretion composition that result from
the growth of P. aeruginosa may have clinical impacts,
membership of CF sputum isolate clusters, as defined based
on PCA and OPLS-DA, for both three and four cluster
models, was compared with a number of potentially key
strain or sputum sample characteristics. These factors were
isolate auxotrophy, mucoidy, pigmentation, spent culture
pH, sputum pH, species richness and relative phyla abun-
dance as defined by 16S rRNA gene clone sequencing
analysis, P. aeruginosa density as determined by quanti-
tative PCR, patient age, sex, genotype, BMI, diabetic sta-
tus, FEV1, and the number of respiratory exacerbations
over the preceding 12 months. Of these, highly significant
relationships were identified between both cluster mem-
bership and lung function (FEV1) (F(3,10) = 5.64,
p = 0.0159) and cluster membership and spent culture pH
(F(3,10) = 8.63, p = 0.004,) (Fig. 3). These significant
relationships were tested using Tukey’s HSD to assess for
significant differences between clusters. In the three cluster
model, this analysis found significant differences between
Fig. 2 Scores scatter plot
resulting from applying PCA to
the 1H NMR data by component
1(PC1) and component 2 (PC2).
The percentage of variance in
the data explained by each
component is indicated on the
relevant axis. Strain
identification numbers are
shown. Ellipses are drawn to
show putative clusters of
spectra. SCFM—synthetic
cystic fibrosis media. The
corresponding loadings plot
provided in the supplementary
material identifies points in the
NMR spectra that align with
either PC1 or PC2
Table 2 Predictive Q2 values for all models
Test 3 cluster model 4 cluster model
SCFM versus cluster I 0.92 (-0.63) 0.92 (-0.63)
SCFM versus cluster IIa 0.99 (-0.44) 0.99 (-0.47)
SCFM versus cluster IIb 0.99 (-0.46) 0.99 (-0.48)
SCFM versus cluster IIc – 0.99 (-0.40)
Cluster IIa versus cluster IIb 0.71 (-0.46) 0.91 (-0.50)
Cluster IIa versus cluster IIc – 0.84 (-0.47)
Cluster IIb versus cluster IIc – 0.92 (-0.44)
Cluster IIa and IIb contain isolates 4, 7, 11, 13, 14 and 2, 5, 9, 12, 13b,
respectively, in the 3 cluster model and lose isolates 2, 4, 5, 14 to
Cluster IIc in the four cluster model. Q2 values for models run with
permutated class assignments are given in parentheses
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Clusters I and IIb (padj = 0.020) and between Clusters IIa
and IIb (padj = 0.030) for lung function (FEV1) with
patients in Cluster IIb having relatively poor lung function
(Fig. 3a). In the four cluster model, Cluster I was shown to
be significantly different from both clusters IIb
(padj = 0.005) and IIc (padj = 0.010) (Supp. Fig. 9). A
possible relationship was also observed between sputum
pH and cluster membership (F(3,10) = 3.06, p = 0.078,
pH ranged from 5.9 to 7.8). A strong negative correlation
was found between FEV1 and spent culture pH (R =
-0.76, p = 0.002) (Fig. 3c) and significant differences in
spent culture pH were observed between Cluster I and both
Clusters IIa and IIb in the three cluster model (Fig. 3b). No
significant correlation was found however between lung
function and sputum pH (R = 0.50, p = 0.067) or between
sputum pH and spent culture pH (R = -0.37, p = 0.188)
(further significant correlations are shown in supplemen-
tary information as are box plots for the four cluster model;
Supp. Fig. 10). Therefore, although Cluster I and Cluster II
are clearly separated in the PCA analysis (by PC1), the
only significant differences that were found both in FEV1
and spent culture pH were between Cluster I and Cluster
IIb with a significant difference in FEV1 also seen between
Clusters IIa and IIb. These clusters are separated in the
PCA analysis by PC2 and hence identification of reso-
nances contributing to PC2, rather than PC1, or OPLS-DA
analyses between these clusters should identify metabolo-
mic changes that correlate with variance in FEV1 or spent
culture pH.
Pseudomonas aeruginosa cell numbers in spent media
were determined by Q-PCR enumeration, with mean values
calculated from analysis of triplicate independent repeat
cultures (Table 1). No significant difference between cul-
tures of separate isolates, or independent repeat cultures of
particular isolates, was observed, and no relationship was
found between P. aeruginosa levels and cluster
membership.
To determine whether the P. aeruginosa isolates
belonging to separate clusters were genetically distinct, or
represented the same strains growing differently, RAPD
PCR analysis was performed. All 15 isolates studied here
were found to represent distinct strain types (Supp.
Fig. 11).
3.5 OPLS-DA identifies characteristic metabolite
consumption and production
The OPLS-DA comparisons of Cluster IIb with Cluster I
(Fig. 4a) and Cluster IIa (Fig. 4b) again support the clus-
tering determined above and allow identification of reso-
nances from metabolites that may be implicated in FEV1
and/or spent culture pH. Plotting normalised spectra from
each of the four clusters, coloured according to cluster,
highlights resonances whose intensity is consistently
altered between clusters (Fig. 5). Comparing the back-
scaled loadings plots for the comparisons between Cluster
IIb and Cluster I and between Cluster IIb and Cluster IIa
identifies metabolites whose differing intensities correlate
with the significant differences identified above for lung
function FEV1 and/or spent culture pH. Notably, levels of
lysine or ornithine appear higher in the spent media of
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isolates in Cluster I or IIa when compared with those from
Cluster IIb, where lung function was poorest, as evidenced
by their characteristic resonances at 3.765 ppm (Fig. 5a)
and 1.465 ppm (Fig. 5b). A resonance characteristic of
leucine at 1.728 ppm (Fig. 5b) is also elevated in spectra of
spent media of isolates in both Clusters I and IIa while a
broad resonance that appears at 6.80 ppm (Fig. 5c), in
many spectra from Cluster IIb isolates, is largely absent
from either Clusters I or IIa. Spectra from isolates in
Cluster IIc are intermediate between spectra from isolates
in either Cluster IIa or IIb for these features. An additional
broad resonance at 5.77 ppm is notable (Fig. 5c) but its
intensity does not correlate with FEV1 and is one of the
main resonances that contributes to the separation of the
isolates by PC1 in the PCA analysis.
4 Discussion
The way in which chronic colonisation by high cell num-
bers of P. aeruginosa affects the composition of airway
secretions in the CF lung is likely to be important in
selecting co-infecting bacterial species, and in modifying
the growth of P. aeruginosa itself, since nutritional sources
are known to influence bacterial community composition in
other contexts (Resat et al. 2012; Dunaj et al. 2012).
Bacterial growth results in both large- and fine-scale
modifications to the composition of the growth medium,
with the former primarily occurring through the utilisation
of compounds as carbon and nitrogen sources and the
production of major metabolites. Since the aim here was to
obtain an indication of the degree to which P. aeruginosa
isolate growth might have a differential impact on CF
airway secretions, an approach that provides a compre-
hensive overview of major compositional changes, 1H
NMR spectroscopy, was employed (Gjersing et al. 2007).
In keeping with previous studies using 1H NMR spectros-
copy, the data presented here show a high degree of
independent-replicate reproducibility, whilst allowing dif-
ferentiation of chemically divergent samples.
A defined synthetic growth medium designed to replicate
the composition of CF lower airway secretions was used as
part of an in vitro model of CF airway conditions. Previous
studies comparing P. aeruginosa gene expression in CF
sputum with that in similar CF synthetic media have shown
bacterial behaviour to be similar in the two contexts (Palmer
et al. 2007; Fung et al. 2010). By combining 1H NMR
spectroscopy with this CF airway growth model, we were
therefore able to assess the degree to which the impact of P.
aeruginosa growth differed between clinical isolates under
conditions approximating those encountered in vivo.
The P. aeruginosa clinical isolates studied here showed
substantial metabolomic differences, and were categorised
into four separate clusters. These variations, particularly in
levels of the amino acids, may reflect differences in energy
strategies employed, and the ability of strains to adapt to
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the low oxygen tensions in muco-purulent CF sputum.
Such differences may be important in vivo given that
amino acid levels have been shown to influence the anti-
biotic susceptibility of P. aeruginosa (Nguyen et al. 2011)
and the growth strategies that they adopt (Bernier et al.
2011; Shrout and Chopp 2006).
Cluster membership was found to be related to culture
pH. Care was taken to exclude the contribution of pH
induced peak shifting through the exclusion of resonances
from MOPS buffer prior to multivariate analysis and
manual bucketing of spectra following the failure of peak
alignment using COW. Visual inspection of the spectra
resulting from each cluster suggested that the observed
isolate clustering is due to differences in levels of media
constituents and metabolites produced/consumed rather
than shifting peaks. Indeed, no relationship was found
between cluster membership and P. aeruginosa cell num-
bers, further supporting divergence driven by growth
strategy rather than cell density. The mechanism by which
P. aeruginosa growth affects pH is not clear, and could
occur either through a change in levels of non-pH neutral
components of the growth media or through proton extru-
sion. However, the impact of P. aeruginosa growth on pH
could have major clinical implications since it has been
shown to influence both bacterial community composition
(Romanowski et al. 2011; Duncan et al. 2009) and
behaviour (Walker and Duncan 2005) in other clinical
contexts, and alterations in airway secretion pH could
affect a number of innate defence processes, such as ciliary
function (Clary-Meinesz et al. 1998) and mucus viscosity
(Inglis et al. 1998).
Importantly, a highly significant relationship was found
between the cluster membership of CF isolates analysed
here and the lung function of the patient from which they
were obtained (as measured by FEV1). This link between
the nutritional modification of the environment by P.
aeruginosa growth and patient lung function has clear
implications for how our understanding of bacterial com-
munity composition in the CF airways needs to develop. A
broad phylogenetic range of species have been reported in
CF respiratory secretion (Rogers et al. 2004), with a
common factor for their establishment in the airways being
access to nutrients they require for growth. However, not
all species common in associated areas, such as the oral
cavity, are routinely reported in CF lower airway secre-
tions. This may be influenced by modification of the
nutritional context of the lower airway secretions by
dominant bacterial species (Kloosterman and Kuipers
2011; Rogosa and Bishop 1964; Nakada and Itoh 2003).
Such nutritional interactions in the CF lower airways are
poorly understood, and require further investigation.
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Fig. 5 Normalised 1H spectra (with excluded regions but otherwise
untreated) of spent media coloured according to cluster membership.
(Cluster I—blue, Cluster IIa—red, Cluster IIb—green, Cluster IIc—
yellow). Spectral regions between 3.5 and 3.85 ppm (a), 5.6 and
6.9 ppm (b) and 1.4 and 1.8 ppm (c) are shown (Color figure online)
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5 Conclusions
In summary, the application of 1H NMR here to deter-
mining the impact of P. aeruginosa clinical isolate growth
within a model CF system reveals substantial metabolomic
differences between isolates. Membership of isolate clus-
ters, defined through PCA, appears to be linked to diver-
gence in metabolite production, with a significant
correlation between cluster membership and spent culture
pH. These findings suggest that P. aeruginosa isolates
employ a range of growth strategies. Further, cluster
membership was found to be significantly correlated with
patient lung function, suggesting that there may be direct
clinical implications for bacterial metabolic strategy
in vivo. A more sophisticated characterisation of the met-
abolic and pH environment of the CF lower airway is now
warranted, with the potential to inform our understanding
of the chronic bacterial infections that typify cystic fibrosis
airway disease.
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